Markets.News

PSNL  PERSONALIS INC

+ add to watchlist

$5.39

personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.

Mkt Cap: $477.97M

52 Week High: $7.79

P/E: -3.54

52 Week Low: $2.83

Dividend: $0.00

Shares Outstanding: 88.68M

This news is delayed by 15 minutes, sign up now to get live news & full features.